Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sun Pharmaceutical Industries Ltd. Call Transcript 2025

Jul 31, 2025

59215_rns_2025-07-31_a6a5b7dd-2cd6-40f5-97c3-fb14a2302c66.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: [email protected] CIN: L24230GJ1993PLC019050

==> picture [60 x 81] intentionally omitted <==

31 July 2025

National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715

Subject - Investor call audio recording

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, further to our intimation dated 15[th] July 2025 regarding earnings call, the audio recording of the call held today is available on our website. The same can be accessed through below link: https://sunpharma.com/wp-content/uploads/2025/07/FY26-Q1-Earnings-Call-Recording-10034071.mp3

For Sun Pharmaceutical Industries Limited

Anoop Digitally signed by Anoop Anjanikumar Anjanikumar Deshpande Date: 2025.07.31 20:19:44 +05'30' Deshpande

(Anoop Deshpande)

Company Secretary and Compliance Officer ICSI Membership No.: A23983

Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives